Delhi AIIMS issues COVID advisory after staffers test positive
"Cover your nose and mouth with elbow/handkerchief/tissue while sneezing and coughing. Maintain personal hygiene and physical distancing," read the advisory.
New Delhi: In view of the recent surge in COVID-19 cases across the country, the All India Institute of Medical Sciences (AIIMS) Delhi has issued an advisory for hospital staff to wear a face mask inside the hospital premises. This comes after a few of the staff tested positive for the infection.
The All India Institute of Medical Sciences (AIIMS) Delhi has issued an advisory for its staff to follow Covid 19 appropriate behaviour after a few of them were tested positive for the infection.
"Must use reusable cloth face cover/surgical mask in the workplace. Ensure proper cleaning and frequent sanitation of the workplace, particularly of the frequently touched surfaces," the AIIMS management said in an advisory on Wednesday.
Also Read:Medical legacy: Delhi AIIMS to set up museum of archives
"Cover your nose and mouth with elbow/handkerchief/tissue while sneezing and coughing. Maintain personal hygiene and physical distancing," read the advisory.
"Gathering especially in canteens must be avoided, a gathering of five or more persons at any place in the office should be avoided. If feeling unwell then should leave the workplace immediately after informing their reporting officers. Such employees should also home quarantine themselves." it added.
All employees who are at higher risk like pregnant employees, older employees or with underlying medical conditions should take extra precautions.
Medical Dialogues team had earlier reported that Serum Institute of India (SII) CEO Adar Poonawalla said it has restarted manufacturing of the COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the company already has six million booster doses of the Covovax vaccine available and adults must take the booster shot. On Covovax which has been approved as a booster dose for 18 years and above, he said, "We have six million doses ready but the demand is exactly zero."
Covovax booster is now on the CoWin app, he said. Covovax is manufactured through technology transfer from Novavax. Reacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand.
Also Read:Union Health Minister inspects COVID mock drill at RML Hospital
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.